These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 18025069

  • 1. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [Abstract] [Full Text] [Related]

  • 2. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ.
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [Abstract] [Full Text] [Related]

  • 3. Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.
    Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Georgiou A, Kafiri G, Tiniakos DG, Margariti K, Manolakopoulos S, Manesis EK, Archimandritis AJ.
    J Clin Gastroenterol; 2010 Apr; 44(4):e87-95. PubMed ID: 19881359
    [Abstract] [Full Text] [Related]

  • 4. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV, Chrysanthos N, Hadziyannis E, Cholongitas E, Manesis EK.
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [Abstract] [Full Text] [Related]

  • 6. Markers of disease activity in chronic hepatitis B virus infection.
    Yalcin K, Degertekin H, Yildiz F, Celik Y.
    Clin Invest Med; 2003 Feb; 26(1):27-34. PubMed ID: 12659467
    [Abstract] [Full Text] [Related]

  • 7. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
    Chu CJ, Hussain M, Lok AS.
    Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
    Kronenberger B, Wagner M, Herrmann E, Mihm U, Piiper A, Sarrazin C, Zeuzem S.
    J Viral Hepat; 2005 May; 12(3):307-14. PubMed ID: 15850472
    [Abstract] [Full Text] [Related]

  • 10. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y, Tang Q, Zhu W, Zhang X, You L.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [Abstract] [Full Text] [Related]

  • 11. [HBV DNA levels, aminotransferase and histological activity in young male patients with HBeAg positive chronic hepatitis B].
    Cho SC, Lee SH, Shinn JJ, Han SH, Roh BJ, Sohn JH, Lee DH, Kee CS.
    Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):44-51. PubMed ID: 12499816
    [Abstract] [Full Text] [Related]

  • 12. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
    Yalçin K, Değertekin H, Alp MN, Tekeş S, Satici O, Budak T.
    Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
    [Abstract] [Full Text] [Related]

  • 13. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, Chauhan R, Bose S.
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [Abstract] [Full Text] [Related]

  • 14. [Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis].
    Li JQ, Zhuang H, Du H, Wang XH, Duan XZ.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):491-3. PubMed ID: 16042881
    [Abstract] [Full Text] [Related]

  • 15. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
    Hopkirk N, Moyes CD, Lucas CR.
    N Z Med J; 2000 Apr 14; 113(1107):114-6. PubMed ID: 10834277
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B.
    Jeng WJ, Sheen IS, Liaw YF.
    Clin Gastroenterol Hepatol; 2010 Jun 14; 8(6):541-5. PubMed ID: 20298811
    [Abstract] [Full Text] [Related]

  • 17. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
    Bozkaya H, Bozdayi M, Türkyilmaz R, Sarioglu M, Cetinkaya H, Cinar K, Köse K, Yurdaydin C, Uzunalimoglu O.
    Hepatogastroenterology; 2000 Jun 14; 47(36):1675-9. PubMed ID: 11149030
    [Abstract] [Full Text] [Related]

  • 18. [Relationship among pathological changes in Liver tissues and level of serum HBV DNA, HBeAg and ALT of 194 patients with chronic hepatitis B].
    Zhao DY, Qin YQ, Tang XM, Liu GZ, Zheng W, Nong HR, Song JJ, Xie QY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar 14; 21(1):35-7. PubMed ID: 17429530
    [Abstract] [Full Text] [Related]

  • 19. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
    Chu CM, Chen YC, Tai DI, Liaw YF.
    Clin Gastroenterol Hepatol; 2010 Jun 14; 8(6):535-40. PubMed ID: 20304099
    [Abstract] [Full Text] [Related]

  • 20. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK, Mostert MC, Niesters HG, Richardus JH, de Man RA.
    Ned Tijdschr Geneeskd; 2008 Jun 21; 152(25):1426-30. PubMed ID: 18624006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.